These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10710120)

  • 1. Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis?
    Przyklenk K; Hata K; Whittaker P; Elliott GT
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):366-75. PubMed ID: 10710120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: role of adenosine.
    Hata K; Whittaker P; Kloner RA; Przyklenk K
    Circulation; 1998 Feb; 97(7):692-702. PubMed ID: 9495306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraplatelet tetrahydrobiopterin plays an important role in regulating canine coronary arterial thrombosis by modulating intraplatelet nitric oxide and superoxide generation.
    Kanaya S; Ikeda H; Haramaki N; Murohara T; Imaizumi T
    Circulation; 2001 Nov; 104(20):2478-84. PubMed ID: 11705828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
    Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
    Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs.
    Yao Z; Rasmussen JL; Hirt JL; Mei DA; Pieper GM; Gross GJ
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):653-63. PubMed ID: 7505370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
    Tosaki A; Maulik N; Elliott GT; Blasig IE; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
    Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion.
    Végh A; György K; Rastegar MA; Papp JG; Parratt JR
    Eur J Pharmacol; 1999 Oct; 382(2):81-90. PubMed ID: 10528142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
    Elliott GT; Mei DA; Gross GJ
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):49-56. PubMed ID: 9676720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide.
    Elliott GT; Comerford ML; Smith JR; Zhao L
    Cardiovasc Res; 1996 Dec; 32(6):1071-80. PubMed ID: 9015409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
    Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ
    J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A.
    Zhao L; Weber PA; Smith JR; Comerford ML; Elliott GT
    J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model.
    Huang J; Rebello SS; Rosenberg LA; Kaneko M; Sakurama T; Lucchesi BR
    Eur J Pharmacol; 1999 Feb; 366(2-3):203-13. PubMed ID: 10082201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering role of nitric oxide in the delayed protective effect of monophosphoryl lipid A in rat heart.
    György K; Muller B; Vegh A; Kleschyov AL; Stoclet JC
    Br J Pharmacol; 1999 Aug; 127(8):1892-8. PubMed ID: 10482921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
    Bertha BG; Sill JC; Berger I; Folts JD; Milde JH
    Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection with ischemic preconditioning and MLA: role of adenosine-regulating enzymes?
    Przyklenk K; Zhao L; Kloner RA; Elliott GT
    Am J Physiol; 1996 Sep; 271(3 Pt 2):H1004-14. PubMed ID: 8853335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine oxidase mediates cyclic flow variations in a canine model of coronary arterial thrombosis.
    Kuwano K; Ikeda H; Oda T; Nakayama H; Koga Y; Toshima H; Imaizumi T
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H1993-9. PubMed ID: 8764249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.